Alan Mendelson has been a partner in the Silicon Valley office since May 2000 and is the Co-chair of the firm’s Life Sciences Industry Group. He is the former Co-chair of Latham’s Emerging Companies Practice Group.

Mr. Mendelson’s practice is primarily targeted toward the representation of emerging and public growth companies, with strong emphasis on companies in the life sciences industry. He has handled and supervised a variety of major business transactions, including venture capital financings, private placements and public offerings, mergers and acquisitions, joint ventures, and other strategic collaborations and commercial transactions.

Mr. Mendelson currently serves on the Board of Directors of the California Healthcare Institute (CHI), the Board of Trustees of The Scripps Research Institute, the Board of Trustees of the UC Berkeley Foundation and the Board of Advisors for the UC Berkeley Department of Chemistry.

Mr. Mendelson was named a member of the recently formed UC Innovation Council to advise UC President Janet Napolitano on technology and entrepreneurship initiatives for the UC system.

From 2005 to 2011, Mr. Mendelson served on the Board of Directors of the Biotechnology Industry Organization (BIO) and is currently a member of the BayBio Board of Directors. He serves as the corporate secretary for many public and private companies.

From 2009 to 2011, Mr. Mendelson served as President of the Cal Alumni Association. Previously, Mr. Mendelson has served as a member of the Board of Regents of the University of California, as the President of the National Kidney Foundation of Northern California, Inc., and as a member of the Board of Overseers Visiting Committee of Harvard Law School. He currently serves as a member of the Major Gifts Council for the Lucile Packard Foundation for Children's Health and as a member of the Board of the American Friends of Rambam Medical Center, Haifa, Israel.